Cara Therapeutics to Webcast Presentation at the Stifel 2016 Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
STAMFORD, Conn., Nov. 08, 2016 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Wingstop Inc. to Participate in Three Upcoming Investor Conferences in New York City
Nov 08, 2016 13:00 pm UTC| Business
DALLAS, Nov. 08, 2016 -- Wingstop Inc. (Nasdaq:WING) (“Wingstop” or the “Company”) today announced that it will participate in three upcoming investor conferences in New York City: On Tuesday, November 15th, 2016...
Zogenix to Participate in Stifel 2016 Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
EMERYVILLE, Calif., Nov. 08, 2016 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Stephen J....
Game Plan Teams Up with Syracuse Athletics to Enhance Life Skills and Career Development Programs
Nov 08, 2016 13:00 pm UTC| Business
GREENVILLE, N.C., Nov. 08, 2016 -- Game Plan, the comprehensive student-athlete development platform that unifies and aligns athletic departments, athletes, and employers, is excited to announce the addition of Syracuse...
Nov 08, 2016 12:57 pm UTC| Business
RICHMOND, Va., Nov. 08, 2016 -- Synalloy Corporation (Nasdaq:SYNL), today announced net sales for the third quarter of 2016 of $34.3 million. This represents a decrease of $3.8 million or 10% when compared to net sales...
Inovalon Clients Outperform Market in Year Over Year Improvement
Nov 08, 2016 12:55 pm UTC| Business
Advanced Analytics and Data-Driven Intervention Platforms SupportMeaningful Quality Outcomes Improvements BOWIE, Md., Nov. 08, 2016 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced,...
Neuralstem Reports Third Quarter 2016 Results
Nov 08, 2016 12:35 pm UTC| Business
GERMANTOWN, Md., Nov. 08, 2016 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, reported its...